These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28323174)

  • 1. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of issues detected by an ICD diagnostic alert that utilizes far-field electrograms: Clinical implications.
    Koneru JN; Kaszala K; Bordachar P; Shehata M; Swerdlow C; Ellenbogen KA
    Heart Rhythm; 2015 May; 12(5):957-67. PubMed ID: 25640632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate disabling of an ICD noise-detection algorithm in pacemaker-dependent patients.
    Welte N; Gang ES; Swerdlow CD; Strik M; Bordachar P; Ploux S
    Pacing Clin Electrophysiol; 2019 Apr; 42(4):478-482. PubMed ID: 30515880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Undersensing by a Noise Detection Algorithm That Utilizes Far-Field Electrograms With Near-Field Bandpass Filtering.
    Koneru JN; Swerdlow CD; Ploux S; Sharma PS; Kaszala K; Tan AY; Huizar JF; Vijayaraman P; Kenigsberg D; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):224-232. PubMed ID: 27957764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
    Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.
    Cao J; Gillberg JM; Swerdlow CD
    Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of an ICD algorithm to detect lead noise and reduce inappropriate shocks.
    Beau S; Greer S; Ellis CR; Keeney J; Asopa S; Arnold E; Fischer A
    J Interv Card Electrophysiol; 2016 Mar; 45(2):225-32. PubMed ID: 26739482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice.
    Jodko Ł; Kornacewicz-Jach Z; Kaźmierczak J; Rzeuski R; Zielonka J; Kaliszczak R; Safranow K
    Cardiol J; 2009; 16(5):432-9. PubMed ID: 19753522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
    Sasaki T; Nakamura K; Naito S
    Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion.
    Duru F; Bauersfeld U; Candinas R
    Europace; 2001 Jan; 3(1):80-4. PubMed ID: 11271957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Electromechanical Coupling to Prevent Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Keene D; Shun-Shin MJ; Arnold AD; Howard JP; Lefroy D; Davies DW; Lim PB; Ng FS; Koa-Wing M; Qureshi NA; Linton NWF; Shah JS; Peters NS; Kanagaratnam P; Francis DP; Whinnett ZI
    JACC Clin Electrophysiol; 2019 Jun; 5(6):705-715. PubMed ID: 31221358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "Pain wave": P‑wave oversensing in subcutaneous ICD.
    Kattih B; Duncker D; König T; Hohmann S; Oswald H; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2016 Jun; 27(2):151-3. PubMed ID: 27084342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopotential Oversensing Is a Major Cause of Inappropriate Shock in Subcutaneous Implantable Defibrillator in Japan.
    Tsutsui K; Kato R; Asano S; Ikeda Y; Mori H; Tawara M; Tanaka S; Hasegawa S; Nakano S; Iwanaga S; Muramatsu T; Matsumoto K
    Int Heart J; 2020 Sep; 61(5):913-921. PubMed ID: 32921668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.